Somalogic Inc
F:76X0
Somalogic Inc
F:76X0
Price:
1.93
EUR
-3.5%
Market Closed
Market Cap:
€364.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Somalogic Inc
F:76X0
|
US |
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
Trent Ltd
NSE:TRENT
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 76X0.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
76X0
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
76X0 Competitors Multiples
Somalogic Inc Competitors
Somalogic Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Somalogic Inc
F:76X0
|
364.2m EUR | 5.2 | -3.3 | 0.2 | 0.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
978.8B USD | 342.7 | 4 057.9 | 1 162.8 | 2 239.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.1B USD | 4.1 | 27.6 | 19.2 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134.9B USD | 5.5 | 37.4 | 19 | 27.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
309.7B CNY | 6.8 | 16.2 | 16.9 | 16.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.3B CHF | 5.4 | 37.3 | 27.7 | 27.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.4B USD | 4.6 | 25.2 | 18.5 | 21.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD | 9.4 | 46.4 | 30 | 37.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.2B USD | 1.8 | 21.7 | 12 | 18 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.4 | 29.5 | 21.9 | 24.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
